Economist and Harvard University professor Gita Gopinath has drawn attention to the scale of India’s air pollution crisis, saying though not much talked about, this had profound economic consequences.
When Arinze Nkemdirim Okere, PharmD, MBA, worked as the pharmacist for a hospital in Tallahassee, Florida, he noticed that ...
Enanta’s portfolio of RSV replication inhibitors with potential for first-in-disease and best-in-disease treatment.
Cereno Scientific (NASDAQ First North: CRNO B), an innovative biotech pioneering treatments to enhance and extend life for people with ...
Phase 1 study of REX-8756 is well underway following FDA clearance of the Investigational New Drug (IND) application in December 2025--In ...
Findings reinforce brilaroxazine’s treatment effect on negative symptoms and other symptom domains in schizophrenia and support ...
Objectives In patients with chronic obstructive pulmonary disease (COPD), severe exacerbations (ECOPDs) impose significant morbidity and mortality. Current guidelines emphasise using ECOPD history to ...
Acquisition strengthens Merck’s cardio-pulmonary portfolio with addition of Ohtuvayre ® (ensifentrine), a first-in-class COPD maintenance treatment, that is expected to grow into the next decade ...
Acquisition strengthens Merck’s cardio-pulmonary portfolio with addition of Ohtuvayre ® (ensifentrine), a first-in-class COPD maintenance treatment, that is expected to grow into the next decade “The ...
Acquisition strengthens Merck’s cardio-pulmonary portfolio with addition of Ohtuvayre® (ensifentrine), a first-in-class COPD maintenance treatment, that is expected to grow into the next decade As ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback